Gilead Sciences (NASDAQ:GILD)

Bull and Bear

Top Analyst Upgrades and Downgrades: Achillion, Monster, Gilead, JCPenney, JDSU, Green Mountain and More

Stocks were firm yet again on Friday morning ahead of the PPI wholesale inflation report. Investors have been trying to decide where to put their money after the recent stock ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Achillion, Gap, GNC, King Digital, Pepsi, Tesla and More

Stocks were firm on Monday morning, looking to add to the recovery bounce from Friday. Investors have now been given an opportunity to look for stocks that have pulled back ...
Read Full Story »
Comcast-Logo

Oppenheimer Adds 5 Triple-Play Rated Stocks to Buy

The tougher the going gets in the stock market, the more investors want to make very sure they have their bets on companies that have every possible attribute working in ...
Read Full Story »
biotech

5 Huge Biotech Catalysts Right Around the Corner for Top Stocks

A brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are trial data, FDA decisions and company presentations coming soon. The ...
Read Full Story »
mutual funds

Credit Suisse’s Top Large-Cap Stocks Being Bought by Mutual Funds

Anytime you have a very long, protracted up-move in the stock market, the portfolio managers at the top growth mutual funds usually have to start taking some profits and reallocate ...
Read Full Story »
nasdaq-logo

The 5 Most Heavily Shorted Nasdaq Stocks: Who Bucked the Trend?

Short sellers shied away from four of the top five most shorted stocks on the Nasdaq between the June 30 and July 15 settlement dates. The outlier was Frontier Communications, ...
Read Full Story »
DNA

You Just Won’t Believe Gilead’s Profit Margins

Gilead Sciences Inc. (NASDAQ: GILD) has now reported its second-quarter earnings. The largest biotech by market cap turned in earnings of $2.36 per share ($3.93 billion) on more than a ...
Read Full Story »
Biotechnology word cloud

Top Biotech Earnings Previews for the Week Ahead

Earnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will ...
Read Full Story »
Biotechnology word cloud

4 Top Biotechs Expected to Beat Earnings Expectations

With earning season just starting to be in full gear, everybody on Wall Street is looking for the earnings angle, and it seems like almost every firm we cover here ...
Read Full Story »
Sirius Logo

7 Most Heavily Shorted Nasdaq Stocks

Here is a look at the seven Nasdaq-traded stocks with the largest number of shares held short as of June 30. Six of the seven experienced declines in short interest, ...
Read Full Story »
Biotechnology word cloud

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

After the biotech stocks were absolutely crushed in the late winter and early spring, many of the top firms we cover on Wall Street were aggressive in their calls to ...
Read Full Story »
apple-logo

Apple Joins the Five Most Heavily Shorted Nasdaq Stocks

A surge in short interest in Apple shares between the May 30 and June 13 settlement dates was enough to lift the tech giant into the top five most shorted ...
Read Full Story »
nasdaq-logo

The Five Most Shorted Nasdaq Stocks

Short sellers continue to hold huge positions in the same handful of Nasdaq stocks, but among them, short interest in Sirius, the Nasdaq-traded stock with the largest short position, surged ...
Read Full Story »
biotech

Short Sellers Remain Vigilant Against Top Biotech Stocks

Short sellers have many reasons to bet against a stock, some of which are hedging or part of a larger theme. Other reasons may be a bet against a company ...
Read Full Story »
95992888

Large Cap Biotech Stocks to Buy Leading the Comeback Rally

After two years of dominant performance in 2012 and 2013, the biotech rally hit a wall in late February, and the top stocks got absolutely hammered. Immediately, the bears jumped ...
Read Full Story »